162 related articles for article (PubMed ID: 16302325)
21. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
[TBL] [Abstract][Full Text] [Related]
22. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
Schachner L; Pestana A; Kittles C
J Am Acad Dermatol; 1990 Mar; 22(3):489-95. PubMed ID: 2138180
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study.
Wolf JE; Kaplan D; Kraus SJ; Loven KH; Rist T; Swinyer LJ; Baker MD; Liu YS; Czernielewski J
J Am Acad Dermatol; 2003 Sep; 49(3 Suppl):S211-7. PubMed ID: 12963897
[TBL] [Abstract][Full Text] [Related]
24. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
[TBL] [Abstract][Full Text] [Related]
25. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V
J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.
Leyden JJ; Berger RS; Dunlap FE; Ellis CN; Connolly MA; Levy SF
Am J Clin Dermatol; 2001; 2(1):33-9. PubMed ID: 11702619
[TBL] [Abstract][Full Text] [Related]
27. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.
Khodaeiani E; Fouladi RF; Amirnia M; Saeidi M; Karimi ER
Int J Dermatol; 2013 Aug; 52(8):999-1004. PubMed ID: 23786503
[TBL] [Abstract][Full Text] [Related]
28. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris.
Alirezaï M; Gerlach B; Horvath A; Forsea D; Briantais P; Guyomar M
Eur J Dermatol; 2005; 15(4):274-8. PubMed ID: 16048758
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
30. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
[TBL] [Abstract][Full Text] [Related]
31. A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris.
Sheehan-Dare RA; Papworth-Smith J; Cunliffe WJ
Acta Derm Venereol; 1990; 70(6):534-7. PubMed ID: 1981436
[TBL] [Abstract][Full Text] [Related]
32. Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne.
Weiss JW; Shavin J; Davis M
Clin Ther; 2002 Oct; 24(10):1706-17. PubMed ID: 12462298
[TBL] [Abstract][Full Text] [Related]
33. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product.
Leyden JJ; Hickman JG; Jarratt MT; Stewart DM; Levy SF
J Cutan Med Surg; 2001; 5(1):37-42. PubMed ID: 11281433
[TBL] [Abstract][Full Text] [Related]
34. Two Randomized, Double-Blind, Split-Face Studies to Compare the Irritation Potential of Two Topical Acne Fixed Combinations Over a 21-Day Treatment Period.
Bhatia N; Bhatt V; Martin G; Pillai R
J Drugs Dermatol; 2016 Jun; 15(6):721-6. PubMed ID: 27272079
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
[TBL] [Abstract][Full Text] [Related]
36. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
Ting W
Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.
Jarratt MT; Brundage T
J Drugs Dermatol; 2012 Mar; 11(3):318-26. PubMed ID: 22395582
[TBL] [Abstract][Full Text] [Related]
38. Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial.
Yentzer BA; Ade RA; Fountain JM; Clark AR; Taylor SL; Fleischer AB; Feldman SR
Cutis; 2010 Aug; 86(2):103-8. PubMed ID: 20919606
[TBL] [Abstract][Full Text] [Related]
39. [Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies].
Gollnick HP; Graupe K; Zaumseil RP
J Dtsch Dermatol Ges; 2004 Oct; 2(10):841-7. PubMed ID: 16281587
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
Eichenfield LF; Lain T; Frankel EH; Jones TM; Chang-Lin JE; Berk DR; Ruan S; Kaoukhov A
J Drugs Dermatol; 2016 Aug; 15(8):962-9. PubMed ID: 27537997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
